Vireo Growth Inc. (CSE: VREO; OTCQX: VREOF) has announced the effectiveness of its Management Services Agreement (MSA) with PharmaCann Inc., which took effect on March 22, 2026. This agreement allows Vireo to manage certain retail assets and properties of PharmaCann in Colorado until the closing of the acquisition, which is anticipated to occur in the second fiscal quarter of 2026, pending regulatory approval. The MSA is part of a broader Asset Purchase Agreement (APA) disclosed previously on December 16, 2025, where Vireo aims to acquire specific retail assets from PharmaCann. As part of the APA, Vireo has delivered 90,740,741 subordinate voting shares into escrow with Odyssey Trust Company, which will remain in escrow until the completion of the acquisition. This strategic move is expected to enhance Vireo's operational capabilities in the cannabis market, particularly in Colorado, and reflects the company's commitment to expanding its footprint in the industry. CEO John Mazarakis expressed excitement about the MSA's effectiveness, emphasizing the opportunity for Vireo's Colorado team to manage PharmaCann's assets during the interim period. The company is focused on executing its growth strategy and leveraging its national portfolio to drive value for its stakeholders.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.